These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4620179)

  • 1. [Endoxan in ovarian cancer].
    Campodónico I; Soldati A; Rodríguez A
    Rev Chil Obstet Ginecol; 1974; 39(3):87-9. PubMed ID: 4620179
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy for advanced ovarian cancer: a prospective randomized trial comparing hexamethylmelamine and cyclophosphamide to doxorubicin and cyclophosphamide.
    Schwartz PE; Lawrence R; Katz M
    Cancer Treat Rep; 1981; 65(1-2):137-41. PubMed ID: 6261948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.
    Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Cancer Res; 1973 Oct; 33(10):2218-20. PubMed ID: 4741927
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma.
    Piver MS; Barlow JJ; Chung WS
    Cancer Chemother Rep; 1975; 59(6):1157-8. PubMed ID: 769956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tissue reaction in ovarian carcinoma after cyclophosphamide (Endoxan) therapy].
    Engeler V; Hanski W
    Pathol Microbiol (Basel); 1969; 33(3):153-60. PubMed ID: 5350583
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancer.
    Izbicki RM; Baker LH; Samson MK; McDonald B; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1573-5. PubMed ID: 922760
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of ftorafur for the treatment of 3d-4th stage].
    Plaude RK; Osman VI; Tabachnik BI; Purinia IZh; Gutman EKh
    Vopr Onkol; 1975; 21(3):44-7. PubMed ID: 1093324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of ovarian cancer with melphalan.
    Rutledge F
    Clin Obstet Gynecol; 1968 Jun; 11(2):354-66. PubMed ID: 4971815
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of ovarian cancer in the Hospital for Women of the Medical Academy in Dresden and its results].
    Schreiber H; Schneck P
    Z Arztl Fortbild (Jena); 1969 Feb; 63(3):167-70. PubMed ID: 5785468
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS; Lele S; Barlow JJ
    Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with large doses of cyclophosphamide of breast cancer with metastases to solid viscera].
    Chrapowicki A
    Wiad Lek; 1971 Dec; 24(24):2323-6. PubMed ID: 5139720
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian carcinoma treated with cyclophosphamide (Endoxan).
    Hsii FP; Jayaratnam FJ; Siang SC
    Singapore Med J; 1968 Sep; 9(3):195-7. PubMed ID: 5710986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Report on the management of advanced ovarian cancer using Endoxan (Asta) and cyclophosphamide preparations].
    Dvorák O; Spirová M
    Zentralbl Gynakol; 1967 Jul; 89(26):940-5. PubMed ID: 5587033
    [No Abstract]   [Full Text] [Related]  

  • 15. Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random series.
    Johnson CE; Decker DG; Van Herik M; Mussey E; Malkasian GD; Jorgensen EO
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):136-41. PubMed ID: 4550548
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer.
    Fleming GF; Waggoner SE; Rotmensch J; Skoog LA; Langhauser C
    Gynecol Oncol; 1997 Apr; 65(1):42-5. PubMed ID: 9103389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.
    Buckner CD; Briggs R; Clift RA; Fefer A; Funk DD; Glucksberg H; Neiman PE; Storb R; Thomas ED
    Cancer Chemother Rep; 1974; 58(5 Pt 1):697-703. PubMed ID: 4426048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.